Sort by
Refine Your Search
-
Listed
-
Field
-
Classification Title: HEMATOLOGY & MEDICAL ONCOLOGY - Program Director & CLIN AST/ASO/FULL Classification Minimum Requirements: Candidates must have a MD/DO and be BE/BC in Hematology and Medical
-
eligibility in Infectious Diseases Eligibility for Florida medical licensure Established independent research program with active R01 (or equivalent) funding Demonstrated scholarly productivity through peer
-
transplantation, obesity, gut microbiome, new technology development, and motility with a state-of-the-art GI motility lab, with a leading gastroparesis program. Multiple collaborative research and clinical trials
-
. Required Qualifications: Required qualifications for this position is a DVM or equivalent degree from an approved institution, completion of a veterinary anatomic pathology residency training program or
-
monitoring. Duties and responsibilities include: Establishing a robust research program Developing a high-quality publication record at UF Supervising Ph.D. students Teaching both undergraduate and graduate
-
concentration in the MPH program. It is also home to two National Institutes of Health training grants. Faculty members are strongly supported by our college level instructional design team for course development
-
comprised of: UF Health Jacksonville, an academic health center near Downtown Jacksonville and home to the area's only adult and pediatric Level I trauma program UF Health North, a 92-bed hospital and
-
the area's only adult and pediatric Level I trauma program UF Health North, a 92-bed hospital and outpatient medical campus in North Jacksonville UF Health Science Center Jacksonville, which encompasses three
-
(electronically, face-to-face and conferences). Participate in practitioner inquiry (research) to support professional learning and inform continuous program improvement. Commit to continuous professional learning
-
Florida and Southeast Georgia. Our trauma program leads approximately 4500 trauma resuscitations per year with about 3000 patients requiring admission. The blunt/penetrating ratio is 85/15%, and 20% have